SUBSCRIBE
SUBSCRIBE

Alcresta

IN THE PRESS
Pharm Country
Data from the ASSURE Study of Long-Term Use of RELiZORB® Published in Journal of Pediatric Gastroenterology and Nutrition
August 2, 2018
 · 
4 min read
Pharm Country
Alcresta Therapeutics Announces RELiZORB® iMMOBILIZED LIPASE CARTRIDGE has been Issued a Unique Q-Code (Q9994) by CMS
June 19, 2018
 · 
1 min read
Pharm Country
Alcresta Therapeutics Presented Results at the North American Cystic Fibrosis Conference from the ASSURE Study: An Evaluation of the Long-Term Use of RELiZORB
November 6, 2017
 · 
4 min read
Business
Alcresta Receives New Innovative Technology Contract From Vizient, Inc. For Relizorb (Immobilized LIPASE) Cartridge
September 20, 2017
 · 
3 min read
Drug Development
Alcresta Announces Positive Results, Relizorb Increased Fat Absorption In Both Adult And Pediatric Patients With Cystic Fibrosis Receiving Enteral Nutrition
July 31, 2017
 · 
4 min read
FDA
Alcresta Snags FDA 510(K) Clearance for Use Of Relizorb in Kids
July 20, 2017
 · 
4 min read
Genetown
Alcresta’ RELiZORB Increases Fat Absorption In Adult And Pediatric Patients With Cystic Fibrosis Receiving Enteral Nutrition
October 31, 2016
 · 
6 min read
Genetown
Bridgemedica And Alcresta Honored As Gold Winners In The 2016 Medical Design Excellence Award (MDEA)
August 1, 2016
 · 
2 min read
Genetown
Alcresta Release: RELiZORB Recognized For Medical Design Excellence
July 28, 2016
 · 
5 min read
Genetown
Alcresta Launches RELiZORB In The U.S.
June 7, 2016
 · 
5 min read
Load More
AWARDS
  • NextGen Class of 2015
JOBS